Back
AstraZeneca Targets Obesity Market with $18.5B CSPC Deal
Back
Stock News
Themes
AstraZeneca Targets Obesity Market with $18.5B CSPC Deal
AstraZeneca Targets Obesity Market with $18.5B CSPC Deal
Edgen Stock
·
Feb 10 2026, 16:58
Share to
Share to
Copy link
AZN
+0.24%
CSPC PHARMA
+1.38%
source:
[1] After spending $18.5 billion to partner with CSPC Pharmaceutical Group, AstraZeneca forecasts double-digit EPS growth.
Recommend
Celanese Q4 Earnings Plunge 54%, Missing Estimates
Feb 17 2026, 23:34
RB Global Beats Q4 Estimates With $1.11 EPS
Feb 17 2026, 23:33
Mercury General Crushes Q4 Forecasts With $3.66 EPS
Feb 17 2026, 23:32
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Feb 10 2026, 16:58Edgen Stock·Feb 10 2026, 16:58
Edgen Stock·Feb 10 2026, 16:58